NACDS Advances Pharmacy in New York Times Letter-to-the-Editor NACDS President & CEO Steven C. Anderson responds to column, “The Unsung Role of the Pharmacist in Patient Health”

2019-01-31T09:45:35-05:00Categories: Press Release|Tags: , |

NACDS has provided a response to “The Unsung Role of the Pharmacist in Patient Health,” a New York Times article published on Jan. 28 that emphasizes the increasingly important role of pharmacists in healthcare delivery.

NACDS Provides Input on HHS’ Healthy People 2030 Initiative Highlights pharmacists’ increasing role as trusted, accessible and effective healthcare providers

2019-01-28T15:05:30-05:00Categories: Press Release|Tags: , |

NACDS has submitted comments containing recommendations for the Department of Health and Human Services’ (HHS) Healthy People 2030 initiative, which develops a new set of evidence-based, 10-year national objectives aimed at improving the health of all Americans.

NACDS Demonstrates Need for DIR Fee Reform in Comments to CMS Supports agency proposal to reduce patients’ out-of-pocket drug costs, reduce overall healthcare costs, improve patient health, and address drastically unfair reimbursement to pharmacies

2019-01-25T11:08:17-05:00Categories: Press Release|Tags: , , , , |

Based on insights from member pharmacies that serve as the front lines of healthcare delivery, the National Association of Chain Drug Stores (NACDS) has submitted extensive and thoroughly documented comments to the Centers for Medicare & Medicaid Services in support of the agency’s proposal to reform direct and indirect remuneration (DIR) fees – reform that relates directly to reducing patients’ out-of-pocket drug costs.

KEY FACTS

  • NACDS’ comments respond to a CMS proposed rule released in November 2018.
  • DIR fees are being misused by payers to claw back reimbursement paid to pharmacies for prescriptions filled for Medicare beneficiaries.
  • Payers penalize pharmacies for alleged failure to reach benchmarks – many of which are vague, undefined, inconsistent, unachievable or outside of the control of pharmacies.
  • Interpretations of specific terms used in Medicare have led to these claw-backs, to higher out-of-pocket drug costs for patients, and to increased healthcare costs overall.
  • NACDS describes: the harm of current DIR practices; support for DIR fee reform and for a properly-aligned pharmacy quality incentive program; ways that reform would reduce patients’ out-of-pocket drug costs and overall healthcare costs; and CMS’ authority to act.

“The proposed changes are consistent with several of the Administration’s priorities, including the goal to reduce prescription drug costs for patients; improve the Medicare program; and use ‘[Department of Health and Human Services] programs to build a value-driven healthcare system. We therefore strongly urge CMS to use its current authority to further update the Part D Program by implementing these much-needed reforms in the final rule…NACDS members’ experiences confirm that the abuses and harms of pharmacy DIR fees are genuine. And the situation is rapidly growing worse, as abusive pharmacy DIR fees continue to grow exponentially. Pharmacies are calling on CMS to eliminate these and other harms now, by implementing reforms to eliminate pharmacy DIR fees.”

– NACDS’ comments to CMS READ FULL PRESS RELEASE READ COMMENTS

Patient Safety Key as NACDS and APhA Oppose Prescription Drug Importation Emphasize commitment to safer, more effective strategies to reduce drug prices and increase access to prescription medications

2019-01-18T13:21:35-05:00Categories: Press Release|Tags: , |

NACDS and the American Pharmacists Association (APhA) expressed concerns about the risks to patient health and the security of the prescription drug supply chain in opposing legislation that would allow for personal and commercial importation of prescription drugs outside of the Food and Drug Administration’s (FDA) oversight.

Presidential Historian Doris Kearns Goodwin to Address NACDS Annual Meeting Latest book – Leadership in Turbulent Times – offers insights for business, politics and policy

2018-12-10T12:24:00-05:00Categories: Press Release|Tags: , |

Goodwin will be able to share first-hand the take-aways from Leadership in Turbulent Times. Published in September 2018, this book – her seventh – presents a road map for aspiring and established leaders, based on her five decades of studying U.S. Presidents.

20th Annual NACDS Foundation Dinner Raises $1.8 Million for Patient-Care Initiatives Dr. Michael Fraser, CEO of ASTHO, receives 2018 Excellence in Patient Care Award

2018-11-29T16:16:30-05:00Categories: Press Release|

The 20th Annual NACDS Foundation Dinner raised more than $1.8 million to help support evidence-based research, pharmacy education and philanthropic initiatives to improve patient outcomes and advance population health. Dr. Michael Fraser, CEO of the Association of State and Territorial Health Officials, received the 2018 Excellence in Patient Care Award.

Pharmacy Groups Praise CMS’ Progress on DIR Fee Reform to Lower Patients’ Out-of-Pocket Drug Costs

2018-11-27T16:38:55-05:00Categories: Press Release|Tags: , |

The National Community Pharmacists Association, the National Association of Chain Drug Stores, and the National Association of Specialty Pharmacy issued a statement regarding the Centers for Medicare & Medicaid Services’ release on Monday of the proposed rule titled “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses."

Dr. Michael Fraser to Receive 2018 Excellence in Patient Care Award at NACDS Foundation Dinner CEO of Association of State and Territorial Health Officials has demonstrated public-health leadership, including work on opioid-abuse epidemic

2018-11-08T08:56:26-05:00Categories: Press Release|

The CEO of Association of State and Territorial Health Officials has demonstrated public-health leadership, including work the help address the opioid-abuse epidemic. Dr. Fraser will accept the award at the 20th Annual NACDS Foundation Dinner on November 28, 2018, at the Sheraton New York Times Square in New York City.

Go to Top